Related Experiment Video
Updated: Aug 6, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Recombinant vaccines based on translocated effector proteins of Salmonella Pathogenicity Island 2
Mohamed I Husseiny1, Florian Wartha, Michael Hensel
1Institut für Klinische Mikrobiologie, Immunologie und Hygiene, FAU Erlangen-Nürnberg, Wasserturmstr. 3-5, D-91054 Erlangen, Germany.
Abstract:
Attenuated live Salmonella enterica are useful carriers for the delivery of heterologous antigens for vaccination. Effector proteins translocated by type III secretion systems (T3SS) of Salmonella have been successfully utilized for antigen delivery. Here we investigated the use of effector proteins of the T3SS encoded by Salmonella Pathogenicity Island 2 (SPI2). We observed that the effector protein SseF is suitable for delivery of various fusion proteins with heterologous antigens. The efficiency of this carrier protein was demonstrated in vaccination experiments with fusion proteins with Listeria monocytogenes protective antigens. SseF can thus be used as a versatile vehicle for translocation of heterologous proteins for vaccination.
Related Concept Videos
Vaccines
Vaccinations
Recombinant DNA
Bacterial Gastroenteritis
Vaccine Production
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

